መነሻTAKP34 • BVMF
add
Takeda Pharmaceutical Co Ltd BDR
የቀዳሚ መዝጊያ
R$80.72
የቀን ክልል
R$80.72 - R$80.72
የዓመት ክልል
R$66.46 - R$84.50
የገበያው አጠቃላይ ዋጋ
6.54 ት JPY
አማካይ መጠን
5.00
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
| (JPY) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ገቢ | 1.18 ት | 12.75% |
የሥራ ወጪ | 540.19 ቢ | -10.33% |
የተጣራ ገቢ | 92.05 ቢ | 291.64% |
የተጣራ የትርፍ ክልል | 7.83 | 270.22% |
ገቢ በሼር | — | — |
EBITDA | 433.99 ቢ | 55.12% |
ውጤታማ የግብር ተመን | 22.84% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
| (JPY) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 859.02 ቢ | 170.09% |
አጠቃላይ ንብረቶች | 14.57 ት | -2.01% |
አጠቃላይ ተጠያቂነቶች | 7.65 ት | -1.92% |
አጠቃላይ እሴት | 6.92 ት | — |
የሼሮቹ ብዛት | 1.59 ቢ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 0.02 | — |
የእሴቶች ተመላሽ | 3.92% | — |
የካፒታል ተመላሽ | 4.57% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
| (JPY) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
የተጣራ ገቢ | 92.05 ቢ | 291.64% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 280.96 ቢ | 41.25% |
ገንዘብ ከኢንቨስትመንት | -75.13 ቢ | -24.02% |
ገንዘብ ከፋይናንስ | -110.04 ቢ | 21.76% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 54.00 ቢ | 3,129.84% |
ነፃ የገንዘብ ፍሰት | 97.22 ቢ | -39.87% |
ስለ
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
12 ጁን 1781
ድህረገፅ
ሠራተኞች
49,281
